Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1978 1
1980 1
1984 2
1985 2
1986 2
1987 3
1989 3
1991 2
1992 3
1993 2
1994 3
1995 5
1996 3
1997 8
1998 2
1999 4
2000 9
2001 4
2002 4
2003 9
2004 10
2005 9
2006 14
2007 17
2008 17
2009 16
2010 17
2011 32
2012 35
2013 43
2014 44
2015 37
2016 49
2017 47
2018 48
2019 44
2020 32
2021 38
2022 32
2023 36
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Paranasal Sinus Polyp"
Page 1
The current findings in eosinophilic chronic rhinosinusitis.
Tsuda T, Suzuki M, Kato Y, Kidoguchi M, Kumai T, Fujieda S, Sakashita M. Tsuda T, et al. Auris Nasus Larynx. 2024 Feb;51(1):51-60. doi: 10.1016/j.anl.2023.08.002. Epub 2023 Aug 11. Auris Nasus Larynx. 2024. PMID: 37574421 Free article. Review.
Chronic rhinosinusitis (CRS) is a persistent inflammatory disease of the nasal cavity and paranasal sinuses. Traditional classification is denoted by the presence (CRSwNP) or absence of nasal polyps (CRSsNP). ...Moreover, various endotypes of CRSsNP have been …
Chronic rhinosinusitis (CRS) is a persistent inflammatory disease of the nasal cavity and paranasal sinuses. Traditional class …
The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
Lee SE, Amin N, Mannent LP, Bachert C, Gross G, Cho SH, Praestgaard A, Siddiqui S, Nash S, Kamat S, Khan AH, Jacob Nara JA. Lee SE, et al. Rhinology. 2023 Dec 1;61(6):531-540. doi: 10.4193/Rhin22.220. Rhinology. 2023. PMID: 37453138
METHODS: Sinus opacification was evaluated using the Lund-Mackay computed tomography (LMK-CT) score and sense of smell using patient-reported loss of smell (LoS) score, University of Pennsylvania Smell Identification Test (UPSIT) score and the 22-item …
METHODS: Sinus opacification was evaluated using the Lund-Mackay computed tomography (LMK-CT) score and sense of smell using p …
Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
Kovacs AJ, Adappa ND, Kuan EC. Kovacs AJ, et al. Ear Nose Throat J. 2021 Jun;100(5):309-313. doi: 10.1177/0145561320980194. Epub 2020 Dec 11. Ear Nose Throat J. 2021. PMID: 33305974 Free article. Review.
BACKGROUND: Chronic rhinosinusitis (CRS) is a common sinonasal disorder which results in significant inflammation in the nasal cavity and paranasal sinuses. Topical nasal steroids play an important role in the treatment of CRS. ...Emerging data have also examined pa …
BACKGROUND: Chronic rhinosinusitis (CRS) is a common sinonasal disorder which results in significant inflammation in the nasal cavity and …
Isolated Sphenoid Sinus Disease in Children.
Kotowski M, Szydlowski J. Kotowski M, et al. Int J Environ Res Public Health. 2023 Jan 2;20(1):847. doi: 10.3390/ijerph20010847. Int J Environ Res Public Health. 2023. PMID: 36613169 Free PMC article.
The rarity of isolated sphenoid sinus disease (ISSD) and the specificity of pediatric populations meant that a separate analysis was required in this study. ...Sixteen children presented chronic isolated rhinosinusitis without nasal polyps, six suffered from mucocel …
The rarity of isolated sphenoid sinus disease (ISSD) and the specificity of pediatric populations meant that a separate analysis was …
Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps.
Avdeeva K, Fokkens W. Avdeeva K, et al. Curr Allergy Asthma Rep. 2018 Mar 24;18(4):25. doi: 10.1007/s11882-018-0776-8. Curr Allergy Asthma Rep. 2018. PMID: 29574586 Free PMC article. Review.
RECENT FINDINGS: This is a narrative review on the current state of endotypes, biomarkers, and targeted treatments in chronic inflammatory conditions of the nose and paranasal sinuses. Different phenotypes of rhinitis and chronic rhinosinusitis (CRS) have been descr …
RECENT FINDINGS: This is a narrative review on the current state of endotypes, biomarkers, and targeted treatments in chronic inflammatory c …
Post-sinus surgery insertion of steroid-eluting bioabsorbable intranasal devices: A systematic review.
Rizan C, Elhassan HA. Rizan C, et al. Laryngoscope. 2016 Jan;126(1):86-92. doi: 10.1002/lary.25460. Epub 2015 Jul 7. Laryngoscope. 2016. PMID: 26154025 Review.
OBJECTIVES/HYPOTHESIS: Postendoscopic sinus surgery corticosteroid administration reduces polyp formation, inflammation, and adhesions. ...Steroid-eluting bioabsorbable intranasal devices were effective in reducing adhesion formation, polyp formation, inflamm …
OBJECTIVES/HYPOTHESIS: Postendoscopic sinus surgery corticosteroid administration reduces polyp formation, inflammation, and a …
Systematic review and meta-analysis of total intravenous anesthesia and endoscopic sinus surgery.
DeConde AS, Thompson CF, Wu EC, Suh JD. DeConde AS, et al. Int Forum Allergy Rhinol. 2013 Oct;3(10):848-54. doi: 10.1002/alr.21196. Epub 2013 Jul 10. Int Forum Allergy Rhinol. 2013. PMID: 23843351 Review.
Although inconsistently reported, preoperative characteristics (Lund-Mackay scores and history of nasal polyps) were similar (p > 0.05) between the 2 groups. ...Standardized grading of visibility scores and preoperative characteristics would better establi …
Although inconsistently reported, preoperative characteristics (Lund-Mackay scores and history of nasal polyps) were similar ( …
Macrophages in CRSwNP: Do they deserve more attention?
Fan HL, Han ZT, Gong XR, Wu YQ, Fu YJ, Zhu TM, Li H. Fan HL, et al. Int Immunopharmacol. 2024 Jun 15;134:112236. doi: 10.1016/j.intimp.2024.112236. Epub 2024 May 13. Int Immunopharmacol. 2024. PMID: 38744174 Review.
Chronic rhinosinusitis (CRS) represents a heterogeneous disorder primarily characterized by the persistent inflammation of the nasal cavity and paranasal sinuses. The subtype known as chronic rhinosinusitis with nasal polyposis (CRSwNP) is distinguished by a signifi …
Chronic rhinosinusitis (CRS) represents a heterogeneous disorder primarily characterized by the persistent inflammation of the nasal cavity …
Systemic Immune Profile in Patients With CRSwNP.
Veloso-Teles R, Cerejeira R, Roque-Farinha R, Buchwald CV. Veloso-Teles R, et al. Ear Nose Throat J. 2021 Sep;100(5_suppl):554S-561S. doi: 10.1177/0145561319893163. Epub 2019 Dec 4. Ear Nose Throat J. 2021. PMID: 31801366 Free article.
The immune pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) remains obscure. Our aim was to compare humoral immunity and white blood cell counts in patients with CRSwNP and controls. ...Patients with CRSwNP had higher IgG1 (P = .022), but lower IgG2 (P = . …
The immune pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) remains obscure. Our aim was to compare humoral immunity …
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52.
Bachert C, Khan AH, Lee SE, Hopkins C, Peters AT, Fokkens W, Praestgaard A, Radwan A, Nash S, Jacob-Nara JA, Deniz Y, Rowe PJ. Bachert C, et al. Int Forum Allergy Rhinol. 2024 Mar;14(3):668-678. doi: 10.1002/alr.23249. Epub 2023 Aug 22. Int Forum Allergy Rhinol. 2024. PMID: 37548085
BACKGROUND: This post hoc analysis of the international SINUS-24/-52 trials (NCT02912468/NCT02898454) aimed to assess dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) according to different definitions of type 2 inflammato …
BACKGROUND: This post hoc analysis of the international SINUS-24/-52 trials (NCT02912468/NCT02898454) aimed to assess dupilumab effic …
582 results